CoChat

The multistep hypothesis of ALS revisited: The role of genetic mutations

Open access

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Amyotrophic lateral sclerosis (ALS) incidence rates are consistent with the hypothesis that ALS is a multistep process. We tested the hypothesis that carrying a large effect mutation might account for ≥1 steps through the effect of the mutation, thus leaving fewer remaining steps before ALS begins. METHODS: genes was performed in 82% of incident cases. As confirmation, we used data from ALS cases diagnosed in the Republic of Ireland (2006-2014). We regressed the log of age-specific incidence against the log of age with least-squares regression for the subpopulation carrying disease-associated variation in each separate gene. RESULTS: . CONCLUSION: The identification of a reduced number of steps in patients with ALS with genetic mutations compared to those without mutations supports the idea of ALS as a multistep process and is an important advance for dissecting the pathogenic process in ALS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000005996

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Slope estimation for all patients with ALS (A) Log incidence vs log age for all patients with incident amyotrophic lateral sclerosis (ALS) who have been genetically tested (n = 1,077) (y = 4.65x − 7.60, r2 = 0.98). (B) Log incidence vs log age for all patients with incident ALS in the register (n = 1,309) (y = 4.83x − 7.85, r2 = 0.99).
Figure 1 Slope estimation for all patients with ALS (A) Log incidence vs log age for all patients with incident amyotrophic lateral sclerosis (ALS) who have been genetically tested (n = 1,077) (y = 4.65x − 7.60, r2 = 0.98). (B) Log incidence vs log age for all patients with incident ALS in the register (n = 1,309) (y = 4.83x − 7.85, r2 = 0.99).CC BY · PubMed Central
Figure 2 Slope estimation for all those with familial ALS Log incidence vs log age for all patients with incident familial amyotrophic lateral sclerosis (ALS) (n = 111) (y = 2.95x − 5.45, r2 = 0.92).
Figure 2 Slope estimation for all those with familial ALS Log incidence vs log age for all patients with incident familial amyotrophic lateral sclerosis (ALS) (n = 111) (y = 2.95x − 5.45, r2 = 0.92).CC BY · PubMed Central
Figure 3 Slope estimation for all patients with ALS carrying a mutation in 1 of 4 tested genes Log incidence vs log age for C9orf72 amyotrophic lateral sclerosis (ALS) (74 cases) (y = 2.22x − 4.33, r2 = 0.94) (red line), for SOD1 ALS (20 cases) (y = 0.758x − 2.43, r2 = 0.53) (green line), and for TARDBP ALS (15 cases) (y = 3.24x − 6.76, r2 = 0.93) (blue line). The fit to a straight line is good, consistent with a multistep model.
Figure 3 Slope estimation for all patients with ALS carrying a mutation in 1 of 4 tested genes Log incidence vs log age for C9orf72 amyotrophic lateral sclerosis (ALS) (74 cases) (y = 2.22x − 4.33, r2 = 0.94) (red line), for SOD1 ALS (20 cases) (y = 0.758x − 2.43, r2 = 0.53) (green line), and for TARDBP ALS (15 cases) (y = 3.24x − 6.76, r2 = 0.93) (blue line). The fit to a straight line is good, consistent with a multistep model.CC BY · PubMed Central
Figure 4 Slope estimation for patients with type 1 and 2 diabetes mellitus Data from Piemonte diabetes register.14 Log incidence vs log age for type 1 diabetes mellitus (y = 0.96x − 0.66, r2 = 0.98) (red line) and type 2 diabetes mellitus (y = 5.28x − 6.78, r2 = 1.0) (blue line).
Figure 4 Slope estimation for patients with type 1 and 2 diabetes mellitus Data from Piemonte diabetes register.14 Log incidence vs log age for type 1 diabetes mellitus (y = 0.96x − 0.66, r2 = 0.98) (red line) and type 2 diabetes mellitus (y = 5.28x − 6.78, r2 = 1.0) (blue line).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 1

  1. Siu J, Perkins E, Cashman NR. Effects of sex and family history on the amyotrophic lateral sclerosis (ALS) multistep model. Amyotroph Lateral Scler 2016; 17: 94.

Cited by

See all 212

Metadata

Authors
Chiò, A., Mazzini, L., D'Alfonso, S., Corrado, L., Canosa, A., Moglia, C., Manera, U., Bersano, E., Brunetti, M., Barberis, M., Veldink, J. H., van den Berg, L. H., Pearce, N., Sproviero, W., McLaughlin, R., Vajda, A., Hardiman, O., Rooney, J., Mora, G., Calvo, A., & Al-Chalabi, A.
Affiliations
  • King's College London (GB)
  • From the “Rita Levi Montalcini” Department of Neuroscience (A. Chiò, A. Canosa, C.M., U.M., M.B., M.B., A. Calvo), University of Torino; Institute of Cognitive Sciences and Technologies (A. Chiò), National Research Council, Rome; ALS Center (L.M., E.B.), Department of Neurology, Azienda Ospedaliera Universitaria Maggiore della Carità; Department of Health Sciences (S.D., L.C.), Interdisciplinary Research Center of Autoimmune Diseases, “Amedeo Avogadro” University of Eastern Piedmont, Novara, Italy;...
Corresponding author
Chiò, Adriano
Venue
Neurology
Published
2018-08-14
Volume
91
Issue
7
Pages
e635-e642
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2883293692
Cited by
212
References
39
Citations by year
2026: 11 · 2025: 26 · 2024: 39 · 2023: 27 · 2022: 29 · 2021: 22 · 2020: 34 · 2019: 16 · 2018: 8
FWCI
13.58
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Neurology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Research Portal (King's College London) (submittedVersion, cc-by)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion, cc-by)
Funders
  • Biogen
  • EU Joint Programme – Neurodegenerative Disease Research (MR/R024804/1, MR/L501529/1)
  • Cytokinetics
  • National Institute for Health and Care Research (ES/L008238/1, FP7/2007–2013, MR/L501529/1, MR/R024804/1)
  • Motor Neurone Disease Association (ALCHALABI-TALBOT/APR14/926-794, AL-CHALABI/APR15/844-791, ALCHALABI-DOBSON/APR14/829-791)
  • Research Councils UK
  • ZonMw
  • Ministero della Salute (259867)
  • Ministero dell’Istruzione, dell’Università e della Ricerca (2007–2013)
  • NIHR Maudsley Biomedical Research Centre (ES/L008238/1, MR/R024804/1, MR/L501529/1)
  • Medical Research Council (FP7/20072013, 259867, ES/L008238/1, MR/R024804/1, MR/L501529/1)
  • Economic and Social Research Council (ES/L008238/1, L008238, MR/L501529/1, MR/R024804/1, FP7/2007-2013)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
amyotrophic lateral sclerosis, disease-associated variants, ALS incidence, age-specific incidence, ALS pathogenesis, genetic susceptibility
MeSH terms
Superoxide Dismutase-1, C9orf72 Protein, Adult, Aged, Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Female, Genetic Testing, Humans, Male, Middle Aged, Mutation, Retrospective Studies, Incidence, Genetic Predisposition to Disease, RNA-Binding Protein FUS

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The multistep hypothesis of ALS revisited: The role of genetic mutations. https://app.cochat.ai/papers/10.1212/wnl.0000000000005996
The paper
Chiò, A., Mazzini, L., D'Alfonso, S., Corrado, L., Canosa, A., Moglia, C., Manera, U., Bersano, E., Brunetti, M., Barberis, M., Veldink, J. H., van den Berg, L. H., Pearce, N., Sproviero, W., McLaughlin, R., Vajda, A., Hardiman, O., Rooney, J., Mora, G., . . . Al-Chalabi, A. (2018). The multistep hypothesis of ALS revisited: The role of genetic mutations. Neurology. https://doi.org/10.1212/wnl.0000000000005996

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.